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Neuroactive steroids are synthesized de novo in brain, yet their
physiological significance remains elusive. We provide bio-
chemical, electrophysiological, and behavioral evidence that
several specific actions of alcohol (ethanol) are mediated by the
neurosteroid 3a-hydroxy-5a-pregnan-20-one (3a,5a-THP; allo-
pregnanolone). Systemic alcohol administration elevates
3a,5a-THP levels in the cerebral cortex to pharmacologically
relevant concentrations. The elevation of 3a,5a-THP is dose-
and time-dependent. Furthermore, there is a significant corre-
lation between 3a,5a-THP levels in cerebral cortex and the
hypnotic effect of ethanol. Blockade of de novo biosynthesis of
5a-reduced steroids using the 5a-reductase inhibitor finas-
teride prevents several effects of ethanol. Pretreatment with
finasteride causes no changes in baseline bicuculline-induced
seizure threshold but reverses the anticonvulsant effect of eth-
anol. Finasteride pretreatment also reverses ethanol inhibition
of spontaneous neural activity in medial septal/diagonal band
of Broca neurons while having no direct effect on spontaneous
firing rates. Thus, elevation of 3a,5a-THP levels by acute eth-
anol administration represents a novel mechanism of ethanol
action as well as an important modulatory role for neurosteroids
in the CNS.
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Steroid hormones have long been recognized as endocrine signals
regulating essential functions such as metabolism, catabolism,
and reproduction. Classically, steroids are recognized for their
genomic action as transcriptional regulators, however they have
been more recently characterized in a nongenomic role of direct
interaction with membrane-bound receptors (for review, see
Rupprecht and Holsboer, 1999). Recent research has indicated
that certain of these steroids can be synthesized in brain without
peripheral precursors and have nongenomic effects that produce
both excitatory and inhibitory actions at various receptor classes
in brain (Paul and Purdy, 1992; Robel and Baulieu, 1995). 3a,5a-
THP is an endogenous pregnane steroid and potent agonist
modulator of the inhibitory neurotransmitter GABAA receptor
subtype. 3a,5a-THP is increased in brain in many stress para-
digms (Purdy et al., 1991; Barbaccia et al., 1996; Barbaccia et al.,
1997), as well as during naturally occurring hormonal fluctuations
such as the estrus cycle (Ichikawa et al., 1974; Paul and Purdy,
1992; Finn and Gee, 1993) and pregnancy (Concas et al., 1998). A
wealth of evidence demonstrates that the anxiolytic, sedative/
hypnotic, and anticonvulsant effects attributed to 3a,5a-THP are
mediated by enhancement of chloride ion conductance through
GABAA receptors in brain (Morrow, 1995).
Behavioral and neurochemical evidence suggests that alcohol
exerts pharmacological effects remarkably similar to GABAA
receptor modulators, including 3a,5a-THP (Suzdak et al., 1986b;
Grobin et al., 1998). Several ethanol effects are enhanced by the
positive GABAA receptor modulators benzodiazepines and bar-
biturates, but are blocked by GABAA receptor antagonists and
inverse agonists (Suzdak et al., 1986a; Nutt and Lister, 1989;
Givens and Breese, 1990; Liu and Deitrich, 1998). For example,
sedative/hypnotic effects produced by high doses of ethanol are
mediated by GABAA receptors and can be enhanced by GABA
agonists and blocked by GABA receptor antagonists (Martz et
al., 1983). However, the conclusion that ethanol has direct effects
on GABAA receptors is controversial. Although ethanol poten-
tiation of GABAA receptor-mediated responses are observed in
Cl2 flux studies, there is a lack of consistent electrophysiological
evidence that ethanol interacts directly with GABAA receptors in
vivo and in vitro. For example, ethanol increases GABA-mediated
inhibition in some brain regions, but not others (Givens and
Breese, 1990; Simson et al., 1991). Whole-cell patch-clamp re-
cording techniques have also provided mixed results concerning
the ability of ethanol to enhance GABA inhibition (Mancillas et
al., 1986; Frye et al., 1994; Marszalec et al., 1998; Sapp and Yeh,
1998).
Because ethanol is known to have effects on the GABAA
receptor, and 3a,5a-THP is such a potent modulator of the same
receptor, we became interested in a possible interaction between
these two agents. Ethanol activates the hypothalamic–pituitary
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axis and has been shown to cause increases in plasma levels of
several steroids, including corticosterone, testosterone, and pro-
gesterone (Rivier et al., 1984; Korneyev et al., 1993b; Schuckit
and Smith, 1996). In this study, we investigated whether ethanol
alters brain levels of the GABAergic neurosteroid 3a,5a-THP
and if steroid biosynthetic enzyme inhibitors prevent this effect.
We also investigated the effect of blockade of steroid biosynthesis
on anticonvulsant and electrophysiological effects of ethanol, as
well as the temporal relationship between 3a,5a-THP elevation
and these effects of ethanol. Our results suggest that 3a,5a-THP
plays a modulatory role in ethanol action at the GABAA receptor
and contributes to certain electrophysiological and behavioral
effects in vivo.
MATERIALS AND METHODS
All experiments were conducted in accordance with National Institutes
of Health Guidelines under Institution Animal Care and Use
Committee-approved protocols. Male Sprague Dawley rats (200–240 gm)
were purchased from Harlan (Indianapolis, IN) and were group-housed
in controlled conditions (lights on, 6:00 A.M. to 6:00 P.M.) with ad
libitum access to rat chow and water. All animals were handled and
habituated to vehicle injections for 5 d before experiments. All experi-
ments were performed at the beginning of the light cycle to minimize
diurnal steroid fluctuations.
Radioimmunoassays. RIAs were performed as described previously (Ja-
nis et al., 1998). Steroids were extracted from individual cerebral cortical
hemispheres that were rapidly dissected in ice-cold saline after euthana-
sia. Cortices were then frozen at 280°C until use. Recovery was moni-
tored by the incorporation of 4000 dpm of [ 3H]3a,5a-THP. Samples were
digested in 0.3 N NaOH by a sonic dismembrator and extracted three
times in 3 ml aliquots of 10% (v/v) ethyl acetate in heptane. The aliquots
were combined and diluted with 4 ml of heptane. The extracts were
applied to solid phase silica columns (Burdick & Jackson, Muskegon,
MI), washed with pentane, and steroids of similar polarity to 3a,5a-THP
were eluted off of the column by the addition of 25% (v/v) acetone in
pentane. The eluant was then dried under N2 and steroids were redis-
solved in 20% (v/v) isopropanol RIA buffer (0.1 M NaH2PO4, 0.9 M
NaCl, 0.1% w/v BSA, pH 7.0). Extraction efficiency was determined in
50 ml of the redissolved extract by liquid scintillation spectroscopy.
Extraction efficiency ranged between 95 and 100%. The remaining 200
ml was used in the determination of 3a,5a-THP by radioimmunoassay.
Reconstituted sample extracts (75 ml) and 3a,5a-THP standards (5–
40,000 pg in 6.25% v/v ethanol, 31% v/v isopropyl alcohol in RIA buffer)
were assayed in duplicate by the addition of 725 ml of RIA buffer, 100 ml
of [ 3H]3a,5a-THP (20,000 dpm), and 100 ml of anti-3a,5a-THP antibody
(1:500; gift of CoCensys, Irvine, CA). Total binding was determined in
the absence of unlabeled 3a,5a-THP, and nonspecific binding was de-
termined in the absence of antibody. The antibody-binding reaction was
allowed to equilibrate for 120 min at room temperature and was termi-
nated by cooling the mixture to 4°C. Bound 3a,5a-THP was separated
from unbound 3a,5a-THP by incubation with 300 ml of cold dextran-
coated charcoal (DCC; 0.04% dextran, 0.4% powdered charcoal in
double-distilled H2O) for 20 min. DCC was removed by centrifugation at
2000 3 g for 10 min. Bound radioactivity in the supernatant was deter-
mined by liquid scintillation spectroscopy. Sample values were compared
to a concurrently run 3a,5a-THP standard curve (0, 0.005, 0.01, 0.02,
0.04, 0.08, 0.16, 0.31, 0.62, 1.25, 2.5, 5.0, 10.0, 20.0, and 40.0 ng/tube)
produced using a one-site competition model (Prism2; GraphPad, San
Diego, CA). Sample values were adjusted to account for the previously
determined extraction efficiency. The sensitivity of the assay was 15–20
pg/tube, and the interassay coefficient of variation was 9.1%.
Administration of biosynthesis inhibitors. Finasteride (Sigma, St. Louis,
MO), a 5a-reductase inhibitor, was administered 4 and 1.5 hr before
ethanol injection. It was administered subcutaneously in a 2 ml/kg
suspension of finasteride in 20% (w/v) 2-hydroxypropyl-b-cyclodextrin
(HCD) (Research Biochemicals, Natick, MA) at either a 25 or 50 mg/kg
dose. Doses of finasteride were determined by review of finasteride use
in previous behavioral and biochemical experiments in rodents (Lephart
et al., 1996; Concas et al., 1998; Kokate et al., 1999). Finasteride (50
mg/kg, s.c.) alters open field behavior in pregnant females rats and
decreased enzyme activity by 60–80% (Lephart et al., 1996).
Indomethacin (ICN Biomedicals, Aurora, OH), a 3a-HSD inhibitor,
was administered 20 min before ethanol injection. Indomethacin was
administered in a 1 ml/kg solution of 20% HCD, intraperitoneally, at a
dose of 0.1 mg/kg. This dose has been reported to block 3a,5a-THP
formation in a pseudopregnant rat model (Smith et al., 1998a).
Trilostane (Sanofi, Malvern, PA), a 3b-HSD inhibitor, was adminis-
tered 2 hr before ethanol injection. Trilostane was administered in a 2
ml/kg solution of 20% HCD, intraperitoneally at a dose of 30 mg/kg.
This dose has been reported to significantly decrease conversion of
pregnenolone to progesterone (Potts et al., 1978; Korneyev et al., 1993b).
Loss of righting reflex . Ethanol-induced sleep time was determined by
the duration of the loss of righting reflex, defined as the inability to right
three times in 1 min after placement in the supine position. Ethanol (3.5
gm/kg; 20% v/v in saline) was administered by intraperitoneal injection;
rats were replaced in their cage until righting reflex was lost and then
placed in a V-shaped support in the supine position until recovery. Rats
were administered finasteride (25 or 50 mg/kg) or vehicle [20% (w/v)
2-hydroxypropyl-b-cyclodextrin; Research Biochemicals] subcutane-
ously, 4 and 1.5 hr before ethanol administration.
Seizure thresholds. Rats were administered finasteride (25 or 50 mg/kg)
or vehicle [20% (w/v) 2-hydroxypropyl-b-cyclodextrin] subcutaneously, 4
and 1.5 hr before intraperitoneal ethanol administration. Seizure thresh-
old was measured either 10 or 40 min after ethanol (2.0 gm/kg) admin-
istration. Rats were gently restrained for insertion of a 25 ga butterfly
needle into the lateral tail vein, then held lightly by the tip of the tail
while allowed free movement. Bicuculline (0.05 mg/ml) was infused at a
rate of 1.6 ml/min until the first myoclonic twitch of the face and/or neck.
Seizure threshold (milligrams per kilogram) was calculated as the dura-
tion of infusion 3 dose of bicuculline/body weight.
Single-cell electrophysiolog ical recordings. Rats were anesthetized with
urethane (1.5 gm/kg) and placed in a stereotaxic frame. An incision was
made in the skin, the skull surface was cleaned, and a burr hole was
drilled through the skull 0.3 mm anterior and 1.5 mm lateral of bregma.
Single-barrel glass micropipettes were pulled (using Model PE-2; Nar-
ishige, Tokyo, Japan) and the tip was broken back to ;1.0 mm and filled
with a 0.9 M NaCl solution saturated with Chicago sky-blue dye. The
electrode was lowered into the medial septum/diagonal band of Broca
(MS/DB) via a hydraulic microdrive (Trent Wells, South Gate, CA).
Extracellular action potentials were amplified, filtered (300 Hz and 8
kHz; Fintronics, Orange, CT), and were monitored with a Tektronix
oscilloscope and audiomonitor. Individual action potentials isolated from
background activity with at least 3:1 signal-to-noise ratios, constant
duration/configuration, and rhythmically bursting patterns were defined
as single MS/DB neurons using previously published criteria (Givens and
Breese, 1990). Individual action potentials were digitized by a window
discriminator (Fintronics), and the pulse was fed into an IBM personal
computer that generated 10 sec time bin ratemeter histograms.
After isolation of a single MS/DB neuron, at least a 5 min baseline of
spontaneous neural activity was collected, after which rats received a 1.5
gm/kg ethanol (10% w/v) intraperitoneal injection; thereafter, an addi-
tional 60 min of spontaneous activity was recorded. Care was taken to
monitor the waveform of the action potential, and the electrode location
was micromanipulated to prevent waveform alterations. After completion
of the recording, a current was passed through the electrode, thereby
depositing dye and marking its location. The brain was then removed
from the animal, frozen, and sliced to verify electrode location. All
neurons analyzed were located in the MS/DB (data not shown).
Statistics. Statistical analysis was done with Statview (Abacus Con-
cepts, Berkeley, CA) and GraphPad Prism (GraphPad Software).
RESULTS
Ethanol induction of 3a,5a-THP in cerebral cortex
Levels of 3a,5a-THP in cerebral cortex were dramatically in-
creased 60 min after acute ethanol administration (1.3–4.0 gm/
kg, i.p.; 20% v/v in saline) to male Sprague Dawley rats (Fig. 1A).
Changes in cerebral cortical levels of 3a,5a-THP induced by
ethanol were dose-dependent (Fig. 1A). There was a smaller
3a,5a-THP response at 4.0 gm/kg ethanol, but all doses mea-
sured beyond 1 gm/kg were significantly elevated above saline
controls (one-way ANOVA, F 5 13.20, p , 0.0001; Dunnett’s post
hoc, p , 0.05). Doses of ethanol from 2–3 g/kg caused increases
in 3a,5a-THP levels in cortex from 2.7 ng/gm to 10–12 ng/gm.
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The effect of ethanol (2 gm/kg, i.p.) was observed 20 min after
ethanol injection and peaked between 40 and 80 min (Fig. 1B).
3a,5a-THP levels in cerebral cortex of saline-injected rats were
only mildly elevated at 20 min after injection and returned to
baseline conditions by 40 min (Fig. 1B). Hence, the stress asso-
ciated with injection did not significantly contribute to cerebral
cortical levels of 3a,5a-THP in ethanol-treated rats. Plasma levels
of progesterone and corticosterone were positively correlated
after ethanol administration (r 5 0.829; p , 0.0001); however,
these levels did not correlate with ethanol-induced increases in
cerebral cortical 3a,5a-THP levels (r 5 0, p 5 0.964; r 5 0.179,
p 5 0.371, respectively; see Table 2). Moreover, cerebral
cortical 3a,5a-THP levels did not correlate with plasma 3a,5a-
THP levels measured between 0 and 120 min (r 5 0.269, p 5
0.074; see Table 2).
Ethanol-induced elevations of 3a,5a-THP levels could occur
via several mechanisms, including modulation of de novo biosyn-
thesis, catabolism, or endogenous steroid release. To determine if
3a,5a-THP levels are increased after ethanol exposure as a result
of de novo biosynthesis, the effects of steroid biosynthesis inhib-
itors were investigated. Three of these inhibitors were used, the
3b-hydroy x steroidox idoreductase/i somerase inhibitor
trilostane, the 5a-reductase inhibitor finasteride, and the 3a-
hydroxysteroidoxidoreductase inhibitor indomethacin (Potts et
al., 1978; Penning et al., 1985; Steiner, 1996). The irreversible
steroid 5a-reductase type II inhibitor finasteride was the only
inhibitor that reduced the effect of ethanol on cerebral cortical
3a,5a-THP and plasma corticosterone levels (Table 1). As pre-
viously reported, indomethacin paradoxically increased 3a,5a-
THP levels over those of ethanol-induced 3a,5a-THP in cortex
(Morrow et al., 1998), while still decreasing corticosterone levels
(Table 2). Trilostane reduced plasma progesterone levels, but had
no effect on ethanol-induced changes in cortical 3a,5a-THP or
plasma corticosterone.
3a,5a-THP modulation of ethanol-mediated behaviors
Having established that acute ethanol administration increases
cerebral cortical 3a,5a-THP levels, we investigated the hypothe-
sis that 3a,5a-THP contributes to the behavioral effects of etha-
nol. Because the sedative–hypnotic effects of ethanol involve the
activation of GABAA receptors, we investigated whether ethanol-
induced 3a,5a-THP levels in the cerebral cortex were correlated
with the hypnotic effect of ethanol. Male Sprague Dawley rats
were injected with 3.5 gm/kg ethanol [20% (w/v) in saline], and
sleep time was measured from loss of righting reflex until righting
reflex recovered. Cerebral cortical 3a,5a-THP levels were clearly
correlated (r 5 0.59; p , 0.0001) with ethanol-induced sleep time
(Fig. 2).
Acute ethanol administration has been shown to increase
bicuculline-induced seizure threshold in rats (Rastogi et al., 1986;
Glowa et al., 1988; Nutt and Lister, 1989). Ethanol administration
(2 gm/kg) increased bicuculline seizure threshold 40 min, but not
10 min after ethanol administration (two-way ANOVA, effect of
drug, p , 0.02; Tukey’s multiple comparison, *p , 0.02) (Fig.
3A). This time course of anticonvulsant action correlates with the
time course of ethanol induction of cerebral cortical 3a,5a-THP
levels (Fig. 1B). Pretreatment with finasteride (50 mg/kg, s.c.)
under the same experimental conditions completely prevented
Figure 1. Cerebral cortical 3a,5a-THP levels are elevated after acute,
systemic ethanol administration. A, Cerebral cortical 3a,5a-THP levels
exhibit a biphasic response to increasing ethanol concentrations. Ethanol
increased 3a,5a-THP levels to pharmacologically active concentrations at
doses between 1.35 and 4.0 gm/kg (*p , 0.0001, ANOVA; p , 0.05,
Dunnett’s post hoc) measured 60 min after ethanol administration. Data
represent mean 6 SEM of duplicate determinations in 6–10 rats per dose
from two independent experiments. Further analysis of trend shows a
significant match to a quadratic equation (F(1,32) 5 17.49; p , 0.05) using
random samples of five rats per dose. B, Cerebral cortical 3a,5a-THP
levels peak between 40 and 80 min after an injection of ethanol (2 gm/kg,
i.p.) followed by a gradual decrease. Data shown are the mean 6 SEM of
a representative experiment repeated twice with similar results (n 5
6/time point; *p , 0.05 Dunnett’s post hoc).
Table 1. Levels of plasma steroids after ethanol administration
Steroid 0 min 20 min 40 min 80 min 120 min 150 min 200 min
Allopregnanolone (ng/ml) 0.068 6 0.016 1.35 6 0.18 1.35 6 0.092 1.43 6 0.088 1.78 6 0.54 0.74 6 0.22 0.455 6 0.18
Progesterone (ng/ml) 2.02 6 0.78 93.3 6 8.2 95.3 6 6.0 106 6 3.7 67.2 6 16 44.2 6 11 15.2 6 5.3
Corticosterone (ng/ml) 54.3 6 15 386 6 99 517 6 35 597 6 82 481 6 83 391 6 43 174 6 45
Ethanol was administered (2 gm/kg, i.p., 20% ethanol in saline w/v), and animals were euthanized 0, 20, 40, 80, 120, 150, or 200 min after injection. Animals euthanized
at 0 min were killed immediately after injection. Each group represents a minimum of six animals, and all measurements were made from aliquots of the same plasma.
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the anticonvulsant effect of ethanol on bicuculline seizure thresh-
old (ANOVA, F 5 5.476, p , 0.01; Tukey’s multiple comparison,
†p , 0.05) (Fig. 3B).
3a,5a-THP modulates electrophysiological actions
of ethanol
The ability of finasteride to modulate ethanol-induced effects on
neural activity in the brain was investigated by monitoring spon-
taneous firing rates of MS/DB neurons. MS/DB cells show a high
rate of spontaneous firing (Givens and Breese, 1990) that was
inhibited by a maximum of 38.0 6 1.52%, 20–40 min after
systemic injection (Fig. 4A). Although maximal inhibition was
between 20 and 40 min, spontaneous firing was inhibited from
baseline throughout the recording period. Previous work has
shown that complete recovery is not attained until 90 min (Givens
and Breese, 1990). Finasteride pretreatment reversed the inhibi-
tion of spontaneously active MS/DB neurons produced by sys-
temic ethanol administration ( p , 0.0001, two-way ANOVA with
repeated measures; main effect of finasteride, F(2,152) 5 34.77;
Fig. 4A). Pretreatment with finasteride (25 mg/kg) prevented
ethanol-induced inhibition of spontaneously active MS/DB neu-
rons from 20–29 min [Tukey’s post hoc test, q 5 6.213, p , 0.01
(20–24 min time bin); q 5 4.99, p , 0.01 (25–29 min time bin)]
but not after 30 min. In contrast, the higher finasteride dose (50
mg/kg) prevented ethanol-induced inhibition throughout the 60
min recording period [Tukey’s post hoc test, q 5 6.839, p , 0.001
(20–24 min time bin); q 5 5.529; p , 0.01 (25–29 min time bin);
q 5 4.626; p , 0.05 (30–34 min time bin); q 5 4.907, p , 0.05
(35–39 min time bin); q 5 4.649, p , 0.05 (45–49 min time bin)].
Baseline spontaneous neural activity was not altered by finas-
teride pretreatment (one-way ANOVA; F(2,13) 5 2.13; p . 0.05;
Fig. 4B). Baseline firing rates for the ethanol only group ranged
from 12.5–59.1 Hz, the ethanol 1 25 mg/kg finasteride group
ranged from 14.2–31.6 Hz, and the ethanol 1 50 mg/kg finas-
teride group ranged from 10.9–23.3 Hz. Moreover, the time
course of the onset of ethanol inhibition of spontaneous neural
activity in the MS/DB is very similar to the time course of
ethanol-induced 3a,5a-THP elevation in cerebral cortex. How-
ever, the time course of the recovery of MS/DB spontaneous
neural activity precedes the time course of return to baseline
3a,5a-THP levels in cortex.
DISCUSSION
These data reveal an important interaction between ethanol and
the endogenous pregnane neurosteroid 3a,5a-THP. Ethanol in-
duces a dose- and time-dependent increase in cerebral cortical
3a,5a-THP levels to physiologically relevant concentrations. The
time course of the induction of this potent GABA modulator at a
moderate ethanol dose correlates with the appearance of specific
behavioral and electrophysiological effects of ethanol. These ef-
fects are reversed when 3a,5a-THP induction is reduced by
finasteride, indicating that 3a,5a-THP mediates or modulates
some GABAergic effects of ethanol.
Ethanol induces an increase in cortical 3a,5a-THP levels suf-
ficient to potentiate GABAA receptor-mediated inhibition in
brain (Harrison et al., 1987; Morrow et al., 1987). The maximal
induction of cortical 3a,5a-THP by ethanol is greater than the
induction of 3a,5a-THP triggered by various stressors (Purdy et
al., 1991; Barbaccia et al., 1996). It is interesting to note that
moderate doses of ethanol induced the largest 3a,5a-THP re-
sponses at the 60 min time point. This could be reflective of a
Figure 2. Elevations in cerebral cortical 3a,5a-THP are related to the
hypnotic effect of ethanol. Alcohol (3.5 gm/kg, i.p.) was administered to
male rats. The duration of the loss of righting reflex (sleep time) was
correlated (r 5 0.59; p , 0.0001; n 5 37) with cerebral cortical 3a,5a-THP
levels measured after awakening.
Table 2. Effects of steroid biosynthetic enzyme inhibitors
Treatment groups






Saline 1.93 6 0.34 3.40 6 0.90 98.5 6 23 14
Ethanol 10.5 6 0.87 87.6 6 7.3 476 6 29 18
Ethanol 1 trilostane 10.4 6 0.92 37.3 6 7.3* 7
Ethanol 1 finasteride 5.9 6 1.0* 66.7 6 8.9 202 6 1.0* 6
Ethanol 1 indomethacin 14.9 6 89* 72.3 6 13 32.4 6 13* 7
*Significantly different from ethanol alone p , 0.01.
Steroid biosynthetic enzyme inhibitors differentially alter ethanol effects on cerebral cortical 3a,5a-THP levels. Ethanol (2
gm/kg, i.p.) was administered, and 3a,5a-THP levels were measured in cerebral cortex 1 hr after ethanol administration.
Trilostane was administered 30 mg/kg, i.p. 1 hr before ethanol. The 5a-reductase inhibitor finasteride was administered 25
mg/kg, s.c., 4 and 1.5 hr before ethanol. The 3a-hydroxysteroid oxidoreductase inhibitor indomethacin was administered 0.1
mg/kg, i.p., 20 min before ethanol (Morrow et al., 1998). Cortical allopregnanolone levels were significantly decreased with
finasteride pretreatment and significantly increased with indomethacin pretreatment, one-way ANOVA, F 5 30.99, df 5
4,47, p , 0.0001 with Dunnett’s multiple comparison post hoc ( p , 0.05 for both finasteride and indomethacin).
Pretreatment with trilostane increased plasma progesterone levels, one-way ANOVA, F 5 26.05, df 5 4,47, p , 0.0001 with
Dunnett’s multiple comparison post hoc ( p , 0.01). Pretreatment with finasteride and indomethacin decreased plasma
corticosterone levels, one-way ANOVA, F 5 34.29, df 5 3.41, p , 0.0001 with Dunnett’s multiple comparison post hoc ( p ,
0.01 for both finasteride and indomethacin).
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varying time course in the elevation of 3a,5a-THP levels. Alter-
natively, this may indicate ethanol effects on 3a,5a-THP biosyn-
thetic enzyme kinetics or desensitization to ethanol. Similar bi-
phasic effects of ethanol and barbiturates on GABAA receptor-
mediated Cl2 flux (Schwartz et al., 1986) have previously been
observed.
The observation that brain 3a,5a-THP levels do not correlate
with plasma corticosterone (a peripheral indicator of HPA axis
activity), progesterone (a precursor of 3a,5a-THP), or plasma
3a,5a-THP itself suggests that brain steroid levels may be differ-
entially regulated from circulating steroids. The absence of a
correlation between central and circulating 3a,5a-THP levels
could be attributable to different time courses for steroid produc-
tion or metabolism between the periphery and brain. Although it
is premature to conclude that brain levels are independent of
peripheral steroid sources, evidence suggests that neurosteroid
biosynthesis in brain may include novel nonenzymatic pathways
(Lieberman and Prasad, 1990; Prasad et al., 1994; Cascio et al.,
1998).
The corroboration of single-cell recording data demonstrates
the specific physiological role of ethanol-induced 3a,5a-THP in
vivo. Ethanol suppression of MS/DB spontaneous activity is tem-
porally correlated with the increase in cortical levels of 3a,5a-
THP and reversed by finasteride pretreatment, demonstrating
that 3a,5a-THP contributes to this response. The time course of
the effects of ethanol on spontaneous activity and 3a,5a-THP
levels are very similar, despite differences in the brain regions and
the dose of ethanol. Furthermore, single-cell recordings of the
neighboring lateral septum, a brain region in which ethanol does
not alter the spontaneous firing rate of neurons, show no effect of
either ethanol or finasteride (data not shown). The enzymes
responsible for 3a,5a-THP production in the brain are regionally
expressed (Roselli and Snipes, 1984; Korneyev et al., 1993a;
Martini et al., 1996), highlighting the possible importance of
studying the regional modulation of these compounds by ethanol.
The correlation of ethanol-induced loss of righting reflex and
brain 3a,5a-THP levels suggests that 3a,5a-THP contributes to
the hypnotic effect of ethanol, likely via GABAA receptor acti-
vation. The ability of finasteride to block the anticonvulsant effect
of ethanol on bicuculline seizure thresholds further substantiates
the role of 3a,5a-THP in ethanol-induced behavior. The effects
of finasteride on ethanol action provide significant evidence that
neurosteroid intermediaries contribute to ethanol action; how-
ever, because these steroids share many of the same biosynthetic
enzymes, the possible involvement of other 5a-reduced steroids
cannot be ruled out.
In fact, it is known that ethanol increases plasma levels of
several steroids, including corticosterone, testosterone, and pro-
gesterone (Rivier et al., 1984; Korneyev et al., 1993b; Schuckit
and Smith, 1996). Further research is needed to determine if
similar effects are found with other GABAergic neurosteroids
such as 3a,21-dihydroxy-5a-pregnan-20-one or 3a-hydroxy-5b-
pregnane-20-one. Recent studies suggest that 3a,5a-THP also
modulates other ion channels, including the nicotinic acetylcho-
line receptor and the serotonin 5-HT3 receptor, but these effects
require much greater concentrations (10 mM) than observed in
response to ethanol (1–4 gm/kg) (Rupprecht and Holsboer,
1999).
The fact that finasteride inhibits some of the GABAergic
effects of ethanol suggests that ethanol may alter the biosynthesis
of 3a,5a-THP. Because finasteride is selective for 5a-reductase
type 2 activity in vivo (Bramson et al., 1997), inhibition of type 1
enzyme activity may be required to obtain complete inhibition of
ethanol effects. However, it appeared that the activity of steroid
biosynthesis inhibitors was altered in the presence of ethanol,
compared to previously published reports (Korneyev et al., 1993b;
Costa et al., 1995; Smith et al., 1998b; Griffin and Mellon, 1999).
For example, trilostane significantly decreased plasma progester-
one levels, but did not change cortical 3a,5a-THP levels. This is
surprising because previous reports suggest that this dose blocks
formation of 3a,5a-THP (Concas et al., 1998). This raises the
possibility that ethanol increases the activity of the 3a-HSD
enzyme, as recently suggested by Griffin and Mellon (1999) in
their study of 3a-HSD kinetics. Further studies are needed to
distinguish if ethanol has direct effects on the neurosteroid bio-
synthetic enzymes or the efficacy of the enzyme inhibitors.
Alternatively, the lack of effect of biosynthesis inhibitors on
ethanol-induced 3a,5a-THP levels may indicate that the eleva-
tion in 3a,5a-THP is independent of de novo biosynthesis of
3a,5a-THP. This could occur if ethanol stimulates the release of
3a,5a-THP from stores in adrenals or glial cells. Finasteride
Figure 3. Anticonvulsant effect of ethanol on bicuculline seizure thresh-
old is reversed by finasteride pretreatment. A, Ethanol (2 gm/kg, i.p.)
increases bicuculline-induced seizure threshold at 40 min, but not 10 min,
after administration (two-way ANOVA, effect of drug, F 5 5.96, p , 0.02;
Tukey’s multiple comparison, *p , 0.02; n 5 11–13). B, Finasteride
pretreatment selectively reverses (ANOVA, F 5 5.476, p , 0.01; Tukey’s
multiple comparison, †p , 0.05; n 5 9–11) the ethanol-induced increase
of seizure threshold.
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pretreatment may have depleted stores of 3a,5a-THP, because it
was administered 4 and 1.5 hr before ethanol, and thereby par-
tially inhibited the effects of ethanol. Further studies are required
to investigate this possibility.
Despite the observation that finasteride had a partial effect on
cortical 3a,5a-THP levels, it is not surprising that finasteride did
not have an effect on baseline seizure threshold and electrophys-
iological measurements. Endogenous levels of 3a,5a-THP in
naı̈ve male rats are very low, certainly below physiologically
relevant concentrations (Purdy et al., 1991). Furthermore, the
dose of finasteride used (50 mg/kg) is below the EC50 for block-
ade of the anticonvulsant effects of progesterone in mice (Kokate
et al., 1999).
Previous studies demonstrated that brain 3a,5a-THP levels are
elevated by the specific serotonin reuptake inhibitors (SSRIs)
fluoxetine and paroxetine (Uzunov et al., 1996; Uzunova et al.,
1998). Because elevations in endogenous 3a,5a-THP levels en-
hance the hypnotic effects of pentobarbital (Matsumoto et al.,
1999), elevations in 3a,5a-THP may also contribute to hypnotic
properties of SSRIs or ethanol. The overlapping effects of ethanol
and SSRIs, such as anxiolytic, sedative, and stress-reducing prop-
erties, may relate to the ability of these drugs to elevate 3a,5a-
Figure 4. Finasteride pretreatment prevents ethanol-induced inhibition of spontaneous neural activity in MS/DB neurons. A, Systemic ethanol injection
(1.5 gm/kg, i.p.) reduced spontaneous neural activity by a maximum of 38.00 6 1.52%, 20–40 min after injection. Finasteride pretreatment reversed the
inhibition of spontaneously active MS/DB neurons produced by systemic ethanol administration ( p , 0.0001, two-way ANOVA with repeated measures;
main effect of finasteride, F(2,152) 5 34.77). Complete blockade of ethanol inhibition was observed between 16 and 25 min after the ethanol injection at
both doses of finasteride. However, only the high dose of finasteride completely blocked ethanol inhibition throughout the recording session. Inset is a
representative oscilloscope trace of medial septum/diagonal band of Broca neuron. B, Baseline firing rate (5 min before ethanol); *p , 0.05; †p , 0.07.
B, A grand mean of ethanol-induced inhibition for each neuron was calculated by collapsing the data across the 12, 5 min time bins. Acute ethanol
administration inhibited the spontaneous activity of MS/DB neurons compared to preinjection baseline (paired t test, T 5 3.12; *p , 0.05). Pretreatment
with 25 mg/kg finasteride did not alter the effect of ethanol on spontaneous firing rate. However, pretreatment with 50 mg/kg finasteride completely
prevented ethanol-induced inhibition of spontaneous MS/DB neural activity (one-way ANOVA, F(2,13) 5 5.45, p , 0.02; Tukey’s post hoc test, q 5 4.593,
†p , 0.05). C, Representative MS/DB neural traces from an animal treated with ethanol only and an animal treated with ethanol 1 50 mg/kg finasteride.
Each neuron was recorded for 60 min after a 1.5 gm/kg ethanol injection (vertical arrow). The neural trace preceding the vertical arrow is the baseline
recording session. Note, ethanol injection resulted in an ;32% inhibition in the MS/DB neuron from the control rat, whereas the ethanol-induced
inhibition was completely blocked by pretreatment with 50 mg/kg finasteride.
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THP levels in brain. However, alcohol and SSRIs each have other
independent neurochemical actions that likely account for other
diverse effects of these drugs. The modulation of 3a,5a-THP
levels by SSRIs and ethanol further support the important role of
3a,5a-THP in the regulation of CNS function.
It is important to note that ethanol affects several ion channels
(Crews et al., 1996). Some effects of ethanol can be observed
minutes after administration. The effects that we measured are
observed at later time points. Anticonvulsant effects of ethanol
and the depression of MS/DB spontaneous activity occur be-
tween 15 and 80 min after ethanol administration and correlate
very well with maximal 3a,5a-THP elevation. Thus, our data
speak directly to 3a,5a-THP modulation of these GABAergic
functions and do not preclude direct ethanol activity at GABAA
receptors or other ion channels.
Other investigators have demonstrated important roles for
3a,5a-THP in ethanol action. In a discriminative stimulus para-
digm, Bowen et al. (1999) showed that GABAergic neurosteroids
substitute for ethanol in both primates and rats. Exogenous
administration of 3a,5a-THP altered ethanol reinforced operant
responding (Janak et al., 1998). Because neurosteroids are such
potent modulators of the GABAergic pathways involved not only
in alcohol action, but also in anxiety, seizure, and movement
disorders, there are possible clinical ramifications of these data. A
specific antagonist of GABAergic neurosteroid action may be
useful in treating alcoholism because of the role we have shown
for 3a,5a-THP in modulating ethanol actions as well as the roles
for 3a,5a-THP in alcohol reinforcement, reward, and perhaps
tolerance (Janak et al., 1998; Bowen et al., 1999).
The identification of a neuroactive steroid as an intermediary
of ethanol actions at GABAA receptors provides an important
example of functional interactions between the genomic and
nongenomic actions of neurosteroids. GABAA receptor function
and mRNA expression are modulated by changes in neurosteroid
levels during pregnancy, and this modulation can be reversed by
finasteride (Concas et al., 1998). In our studies, chronic ethanol
administration reduced basal levels of 3a,5a-THP in cerebral
cortices of male rats (Janis et al., 1998). We have also found that
ethanol-dependent rats are sensitized to the anticonvulsant effect
of 3a,5a-THP during ethanol withdrawal (Devaud et al., 1996).
Moreover, chronic ethanol exposure and withdrawal (Devaud et
al., 1995, 1997; Matthews et al., 1998) have been shown to cause
changes in GABAA receptor a4 subunit mRNA and peptide
expression that mirror the effects of withdrawal from progester-
one and 3a,5a-THP (Smith et al., 1998a). Taken together, these
data demonstrate that neuroactive steroids such as 3a,5a-THP
can elicit synergistic actions involving both nongenomic and
genomic effects on GABAA receptors that enable long-term ad-
aptations in receptor function and expression.
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